Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
- Posted on August 12, 2026
- By The Hill
- 0 Views
- 1 min read
In brief
Generating AI summary…
Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
Eli Lilly is suing six entitles that it alleges are selling black market versions of its experimental weight loss drug retatrutide. Lilly’s lawsuits target U.S. entities selling illegal reta…
